Cited by 3,153CRISPR and Genetic EngineeringRNA regulation and diseaseRNA Interference and Gene Delivery

The DOI matches its Crossref record; 101 of the 102 references it cites were found in a registry or an index.

CRISPR-Cas systems for editing, regulating and targeting genomes

Open access

Sander, Jeffry D, Joung, J Keith·2014·Nature Biotechnology

Open this paper in CoChat — free account

Abstract

Targeted genome editing using engineered nucleases has rapidly gone from being a niche technology to a mainstream method used by many biological researchers. This widespread adoption has been largely fueled by the emergence of the clustered, regularly interspaced, short palindromic repeat (CRISPR) technology, an important new approach for generating RNA-guided nucleases, such as Cas9, with customizable specificities. Genome editing mediated by these nucleases has been used to rapidly, easily and efficiently modify endogenous genes in a wide variety of biomedically important cell types and in organisms that have traditionally been challenging to manipulate genetically. Furthermore, a modified version of the CRISPR-Cas9 system has been developed to recruit heterologous domains that can regulate endogenous gene expression or label specific genomic loci in living cells. Although the genome-wide specificities of CRISPR-Cas9 systems remain to be fully defined, the power of these systems to perform targeted, highly efficient alterations of genome sequence and gene expression will undoubtedly transform biological research and spur the development of novel molecular therapeutics for human disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nbt.2842

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Genome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495

Flagged first, then by citations

Show all 102 references

1 of the 102 references couldn’t be matched to a known paper.

Sorted by citations

Items 901–1,000 of 1,015

Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells
Voets, O., Tielen, F., Elstak, E., Benschop, J., Grimbergen, M., Stallen, J., Janssen, R., van Marle, A., & Essrich, C. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182974 · Cited by 48
Highly Efficient, Rapid and Co-CRISPR-Independent Genome Editing in Caenorhabditis elegans
Prior, H., Jawad, A. K., MacConnachie, L. P., & Beg, A. A. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300216 · Cited by 47
CRISPR in Animals and Animal Models
Shrock, E., & Güell, M. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.010 · Cited by 45
Optimization of a “bump-and-hole” approach to allele-selective BET bromodomain inhibition
Runcie, A. C., Zengerle, M., Chan, K.-H., Testa, A., van Beurden, L., Baud, M. G. J., Epemolu, O., Ellis, L. C. J., Read, K. D., Coulthard, V., et al. (2018) · Chemical Science · doi:10.1039/c7sc02536j · Cited by 47
CRISPR/Cas9 System: A Bacterial Tailor for Genomic Engineering
Lone, B. A., Karna, S. K. L., Ahmad, F., Shahi, N., & Pokharel, Y. R. (2018) · Genetics Research International · doi:10.1155/2018/3797214 · Cited by 48
CRISPR-cas gene-editing as plausible treatment of neuromuscular and nucleotide-repeat-expansion diseases: A systematic review
Babačić, H., Mehta, A., Merkel, O. M., & Schoser, B. G. H. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212198 · Cited by 49
Non-viral delivery of CRISPR/Cas9 complex using CRISPR-GPS nanocomplexes
Jain, P., Lo, J. H.-J., Rananaware, S. R., Downing, M. A., Panda, A., Tai, M., Raghavan, S., Fleming, H. E., & Bhatia, S. N. (2019) · Nanoscale · doi:10.1039/c9nr01786k · Cited by 47
Adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post‐market environmental monitoring of genetically modified insects containing engineered gene drives
(GMO), E. P. O. G. M. O., Naegeli, H., Bresson, J., Dalmay, T., Dewhurst, I. C., Epstein, M. M., Guerche, P., Hejátko, J., Moreno, F. J., Mullins, E. D., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6297 · Cited by 47
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.
Jung, I.-Y., & Lee, J. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.0242 · Cited by 49
Nanotechnology-based siRNA delivery strategies for metastatic colorectal cancer therapy
Sousa, A. R., Oliveira, A. V., Oliveira, M. J., & Sarmento, B. F. C. C. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118530 · Cited by 46
Successive cleavage of β-amyloid precursor protein by γ-secretase
Funamoto, S., Tagami, S., Okochi, M., & Morishima‐Kawashima, M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.04.002 · Cited by 44
Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells
Norbnop, P., Ingrungruanglert, P., Israsena, N., Suphapeetiporn, K., & Shotelersuk, V. (2020) · Scientific Reports · doi:10.1038/s41598-020-65577-x · Cited by 46
Streptomyces: host for refactoring of diverse bioactive secondary metabolites
Sharma, V., Kaur, R., & Salwan, R. (2021) · 3 Biotech · doi:10.1007/s13205-021-02872-y · Cited by 49
Genome Engineering Technology for Durable Disease Resistance: Recent Progress and Future Outlooks for Sustainable Agriculture
Ali, Q., Yu, C., Hussain, A., Ali, M., Ahmar, S., Sohail, M. A., Riaz, M., Ashraf, M. F., Abdalmegeed, D., Wang, X., et al. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.860281 · Cited by 53
Genome editing strategies: potential tools for eradicating HIV-1/AIDS
Khalili, K., Kaminski, R., Gordon, J., Cosentino, L., & Hu, W. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-014-0308-9 · Cited by 51
Future of breeding by genome editing is in the hands of regulators
Jones, H. D. (2015) · GM crops & food · doi:10.1080/21645698.2015.1134405 · Cited by 46
Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application
Alapati, D., & Morrisey, E. E. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0301ps · Cited by 47
Minor collagens of the skin with not so minor functions
Theocharidis, G., & Connelly, J. T. (2017) · Journal of Anatomy · doi:10.1111/joa.12584 · Cited by 56
Single-molecule imaging and tracking of molecular dynamics in living cells
Li, N., Zhao, R., Sun, Y., Ye, Z., He, K., & Fang, X. (2017) · National Science Review · doi:10.1093/nsr/nww055 · Cited by 47
CRISPR/Cas9: the Jedi against the dark empire of diseases
Khan, S., Mahmood, M. S., Rahman, S. U., Zafar, H., Khan, S. H., khan, Z., & Ahmad, A. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0425-5 · Cited by 49
Application of CRISPR-Cas9 for Long Noncoding RNA Genes in Cancer Research
Zhen, S., & Li, X. (2018) · Human Gene Therapy · doi:10.1089/hum.2018.063 · Cited by 48
Detecting and typing target DNA with a novel CRISPR-typing PCR (ctPCR) technique
Zhang, B., Xia, Q., Wang, Q., Xia, X., & Wang, J. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.09.012 · Cited by 46
Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives
Jamebozorgi, K., Taghizadeh, E., Rostami, D., Pormasoumi, H., Barreto, G. E., Hayat, S. M. G., & Sahebkar, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1419-8 · Cited by 46
New Possibilities on the Horizon: Genome Editing Makes the Whole Genome Accessible for Changes
Kawall, K. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00525 · Cited by 50
Recent developments and applications of genetic transformation and genome editing technologies in wheat
Wang, K., Gong, Q., & Ye, X. (2019) · Theoretical and Applied Genetics · doi:10.1007/s00122-019-03464-4 · Cited by 49
Metabolic pathway engineering: Perspectives and applications
Dasgupta, A., Chowdhury, N., & De, R. K. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105436 · Cited by 47
Transformation of naked mole-rat cells
Hadi, F., Kulaberoglu, Y., Lazarus, K. A., Bach, K., Ugur, R., Beattie, P., Smith, E. S. J., & Khaled, W. T. (2020) · Nature · doi:10.1038/s41586-020-2410-x · Cited by 47
Advances and challenges in identifying and characterizing G-quadruplex–protein interactions
Dai, Y., Teng, X., Zhang, Q., Hou, H., & Li, J. (2023) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2023.06.007 · Cited by 46
CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy
Ashraf, M. U., Salman, H. M., Khalid, M. F., Khan, M. H. F., Anwar, S., Afzal, S., Idrees, M., & Chaudhary, S. U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111239 · Cited by 48
CRISPR based therapeutics: a new paradigm in cancer precision medicine
Das, S., Bano, S., Kapse, P., & Kundu, G. C. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01552-6 · Cited by 47
Evolution of Gene Therapy, Historical Perspective
Malech, H. L., Garabedian, E., & Hsieh, M. M. (2022) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2022.05.001 · Cited by 51
CRISPR-Cas9 Gene Editing of the Sal1 Gene Family in Wheat
Mohr, T. J., Horstman, J., Gu, Y., Elarabi, N. I., Abdallah, N. A., & Thilmony, R. L. (2022) · Plants · doi:10.3390/plants11172259 · Cited by 45
Application progress of CRISPR/Cas9 genome-editing technology in edible fungi
Zhang, Y., Chen, S., Yang, L., & Zhang, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1169884 · Cited by 48
Proximity-activated guide RNA of CRISPR–Cas12a for programmable diagnostic detection and gene regulation
Hu, Z., Ling, S., Duan, J., Yu, Z., Che, Y., Wang, S., Zhang, S., Zhang, X., & Li, Z. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf017 · Cited by 46
Genome editing in zebrafish: a practical overview
Sertori, R., Trengove, M. C., Basheer, F., Ward, A. C., & Liongue, C. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elv051 · Cited by 44
Genome editing for targeted improvement of plants
Khandagale, K. S., & Nadaf, A. B. (2016) · Plant Biotechnology Reports · doi:10.1007/s11816-016-0417-4 · Cited by 45
Genetic editing of the androgen receptor contributes to impaired male courtship behavior in zebrafish
Yong, L., Thet, Z., & Zhu, Y. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.161596 · Cited by 45
CRISPR-Cas Systems in Bacteroides fragilis, an Important Pathobiont in the Human Gut Microbiome
Tajkarimi, M. M., & Wexler, H. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02234 · Cited by 45
Combined shRNA over CRISPR/cas9 as a methodology to detect off-target effects and a potential compensatory mechanism
Zats, L. P., Besser, E., Hajbi, R., Casden, N., Ziv, D., Kronenberg, N., Ben-Gigi, L., Sweetat, S., Khawaled, S., Aqeilan, R., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18551-z · Cited by 45
CRISPR-Cas9-mediated generation of obese and diabetic mouse models
Roh, J.-I., Lee, J., Park, S.-U., Kang, Y.-S., Lee, J., Oh, A.-R., Choi, D. J., Cha, J.-Y., & Lee, H. (2018) · EXPERIMENTAL ANIMALS · doi:10.1538/expanim.17-0123 · Cited by 46
New Modalities, Technologies, and Partnerships in Probe and Lead Generation: Enabling a Mode-of-Action Centric Paradigm
Valeur, E., & Jimonet, P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00378 · Cited by 43
Single molecule analysis of effects of non-canonical guide RNAs and specificity-enhancing mutations on Cas9-induced DNA unwinding
Okafor, I. C., Singh, D., Wang, Y., Jung, M., Wang, H., Mallon, J. P., Bailey, S., Lee, J. K., & Ha, T. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz1058 · Cited by 45
Epithelial cell -derived microvesicles: A safe delivery platform of CRISPR/Cas9 conferring synergistic anti-tumor effect with sorafenib
He, C., Ali, D. J., Xu, H., Kumaravel, S., Si, K., Li, Y., Sun, B., Ma, J., & Xiao, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.112040 · Cited by 45
Recent Advances of In Vitro Culture for the Application of New Breeding Techniques in Citrus
Poles, L., Licciardello, C., Distefano, G., Nicolosi, E., Gentile, A., & Malfa, S. G. L. (2020) · Plants · doi:10.3390/plants9080938 · Cited by 45
Efficient CRISPR/Cas9 mediated Pooled-sgRNAs assembly accelerates targeting multiple genes related to male sterility in cotton
Ramadan, M., Alariqi, M., Ma, Y., Li, Y., Liu, Z., Zhang, R., Jin, S., Min, L., & Zhang, X. (2021) · Plant Methods · doi:10.1186/s13007-021-00712-x · Cited by 45
Epigenetic Alterations and Inflammation as Emerging Use for the Advancement of Treatment in Non-Small Cell Lung Cancer
Yang, S., Huang, Y., & Zhao, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.878740 · Cited by 50
Disease modeling by efficient genome editing using a near PAM-less base editor in vivo
Rosello, M., Serafini, M., Mignani, L., Finazzi, D., Giovannangeli, C., Mione, M., Concordet, J., & Bene, F. D. (2022) · Nature Communications · doi:10.1038/s41467-022-31172-z · Cited by 46
Next Generation Natural Killer Cells for Cancer Immunotherapy
Rossi, F., Fredericks, N., Snowden, A., Allegrezza, M. J., & Moreno‐Nieves, U. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.886429 · Cited by 47
Exosome-mediated delivery of CRISPR-Cas9: A revolutionary approach to cancer gene editing
Balaraman, A. K., Babu, M. A., Moglad, E. H. O., Mandaliya, V. B., Rekha, M. M., Gupta, S., Prasad, G. V. S., Kumari, M., Chauhan, A. S., Ali, H., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155785 · Cited by 50
Mouse Models of Tumor Immunotherapy
Ngiow, S. F., Loi, S., Thomas, D. M., & Smyth, M. J. (2016) · Advances in immunology · doi:10.1016/bs.ai.2015.12.004 · Cited by 44
Genome editing and the next generation of antiviral therapy
Stone, D., Niyonzima, N., & Jerome, K. R. (2016) · Human Genetics · doi:10.1007/s00439-016-1686-2 · Cited by 44
Using an Inducible CRISPR-dCas9-KRAB Effector System to Dissect Transcriptional Regulation in Human Embryonic Stem Cells
Parsi, K. M., Hennessy, E., Kearns, N. A., & Maehr, R. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6518-2_16 · Cited by 42
Systems healthcare: a holistic paradigm for tomorrow
Fiandaca, M. S., Mapstone, M. E., Connors, E. E., Jacobson, M., Monuki, E. S., Malik, S., Macciardi, F. M., & Federoff, H. J. (2017) · BMC Systems Biology · doi:10.1186/s12918-017-0521-2 · Cited by 49
Investigating the genetic and epigenetic basis of big biological questions with the parthenogenetic marbled crayfish: A review and perspectives
Vogt, G. (2018) · Journal of Biosciences · doi:10.1007/s12038-018-9741-x · Cited by 44
Progress in Gene Therapy to Prevent Retinal Ganglion Cell Loss in Glaucoma and Leber’s Hereditary Optic Neuropathy
Ratican, S., Osborne, A., & Martin, K. R. G. (2018) · Neural Plasticity · doi:10.1155/2018/7108948 · Cited by 45
CRISPR /Cas9‐mediated specific integration of fat‐1 at the goat MSTN locus
Zhang, J., Cui, M., Nie, Y., Dai, B., Li, F., Liu, D., Liang, H., & Cang, M. (2018) · FEBS Journal · doi:10.1111/febs.14520 · Cited by 44
Translating advances in microbial bioproduction to sustainable biotechnology
Carruthers, D. N., & Lee, T. S. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.968437 · Cited by 44
The Precision Toxicology initiative
The PrecisionTox Consortium (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.05.004 · Cited by 47
Importance of Microorganisms to Macroorganisms Invasions
Amsellem, L., Brouat, C., Duron, O., Porter, S. S., Vilcinskas, A., & Facon, B. (2016) · Advances in ecological research/Advances in Ecological Research · doi:10.1016/bs.aecr.2016.10.005 · Cited by 47
Stem Cells for Modeling and Therapy of Parkinson's Disease
Zhang, Q., Chen, W.-L., Tan, S., & Lin, T. (2016) · Human Gene Therapy · doi:10.1089/hum.2016.116 · Cited by 44
Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells
Li, Z., Levine, K. M., Bahreini, A., Wang, P., Chu, D. T. W., Park, B. H., Oesterreich, S., & Lee, A. V. (2017) · Endocrinology · doi:10.1210/en.2017-00693 · Cited by 42
Modeling rare diseases with induced pluripotent stem cell technology
Anderson, R. H., & Francis, K. R. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.01.001 · Cited by 46
Making ends meet: targeted integration of DNA fragments by genome editing
Yamamoto, Y., & Gerbi, S. A. (2018) · Chromosoma · doi:10.1007/s00412-018-0677-6 · Cited by 49
New CRISPR-Cas9 vectors for genetic modifications of Bacillus species
Toymentseva, A. A., & Altenbuchner, J. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny284 · Cited by 43
Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders
Raikwar, S. P., Kikkeri, N. S., Sakuru, R. C., Saeed, D., Zahoor, H., Premkumar, K., Mentor, S., Thangavel, R., Dubova, I., Ahmed, M. E., et al. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09849-y · Cited by 48
A Cloning-Free Method for CRISPR/Cas9-Mediated Genome Editing in Fission Yeast
Zhang, X., He, J.-B., Wang, Y.-Z., & Du, L. (2018) · G3 Genes Genomes Genetics · doi:10.1534/g3.118.200164 · Cited by 43
Wheat genome editing expedited by efficient transformation techniques: Progress and perspectives
Wang, K., Riaz, B., & Ye, X. (2017) · The Crop Journal · doi:10.1016/j.cj.2017.09.009 · Cited by 45
MET gene exon 14 deletion created using the CRISPR/Cas9 system enhances cellular growth and sensitivity to a MET inhibitor
Togashi, Y., Mizuuchi, H., Tomida, S., Terashima, M., Hayashi, H., Nishio, K., & Mitsudomi, T. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.10.020 · Cited by 44
Genome engineering: Drosophila melanogaster and beyond
Venken, K. J. T., Sarrion‐Perdigones, A., Vandeventer, P. J., Abel, N. S., Christiansen, A. E., & Hoffman, K. L. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.214 · Cited by 43
The Flipside of the Power of Engineered T Cells: Observed and Potential Toxicities of Genetically Modified T Cells as Therapy
Bedoya, F., Frigault, M. J., & Maus, M. V. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.11.011 · Cited by 43
Gene editing nuclease and its application in tilapia
Li, M., & Wang, D. (2017) · 中国科学通报：英文版 · doi:10.1016/j.scib.2017.01.003 · Cited by 42
Comparative analysis of chimeric ZFP-, TALE- and Cas9-piggyBac transposases for integration into a single locus in human cells
Luo, W., Galvan, D. L., Woodard, L. E., Dorset, D. C., Levy, S. A., & Wilson, M. H. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx572 · Cited by 42
Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review
Kalogiannidis, I. A., Kalinderi, K., Kalinderis, M., Miliaras, D., Tarlatzis, B. C., & Athanasiadis, A. P. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-018-1202-9 · Cited by 42
High doses of CRISPR/Cas9 ribonucleoprotein efficiently induce gene knockout with low mosaicism in the hydrozoan Clytia hemisphaerica through microhomology-mediated deletion
Momose, T., Cian, A. D., Shiba, K., Inaba, K., Giovannangeli, C., & Concordet, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-30188-0 · Cited by 42
A Human Polymorphism in CHRNA5 Is Linked to Relapse to Nicotine Seeking in Transgenic Rats
Forget, B., Scholze, P., Vives, F. L., Morel, C., Pons, S., Mondoloni, S., Besson, M., Cuttoli, R. D.-D., Hay, Y. A., Tricoire, L., et al. (2018) · Current Biology · doi:10.1016/j.cub.2018.08.044 · Cited by 41
Reducing phenolic off-flavors through CRISPR-based gene editing of the FDC1 gene in Saccharomyces cerevisiae x Saccharomyces eubayanus hybrid lager beer yeasts
Mertens, S., Gallone, B., Steensels, J., Herrera‐Malaver, B., Cortebeeck, J., Nolmans, R., Saels, V., Vyas, V. K., & Verstrepen, K. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0209124 · Cited by 42
CRISPR/Cas9 gene editing for the creation of an MGAT1-deficient CHO cell line to control HIV-1 vaccine glycosylation
Byrne, G., O’Rourke, S. M., Alexander, D. L., Yu, B., Doran, R. C., Wright, M., Chen, Q., Azadi, P., & Berman, P. W. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005817 · Cited by 42
Genome editing of potato using CRISPR technologies: current development and future prospective
Dangol, S. D., Barakate, A., Stephens, J., Çalışkan, M. E., & Bakhsh, A. (2019) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-019-01662-y · Cited by 43
Present and Future Therapies for Chronic Hepatitis B
Tao, Y.-C., Wu, D., Zhou, L., Chen, E., Liu, C., Tang, X., Jiang, W., Han, N., Li, H., & Tang, H. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9151-4_6 · Cited by 42
Transplantation of hMSCs Genome Edited with LEF1 Improves Cardio-Protective Effects in Myocardial Infarction
Cho, H., Lee, K.-H., Shen, Y., Shin, T.-J., Ryu, P. D., Choi, M., Kang, K., & Cho, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.01.007 · Cited by 42
Combinatorial Modular Pathway Engineering for Guanosine 5′-Diphosphate- l -fucose Production in Recombinant Escherichia coli
Wan, L., Zhu, Y., Li, W., Zhang, W., & Mu, W. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01064 · Cited by 42
Synergetic performance of isothermal amplification techniques and lateral flow approach for nucleic acid diagnostics
Mukama, O., Nie, C., Habimana, J. D. D., Meng, X., Ting, Y., Fanuel, S., AL-Farga, A. M., Mugisha, S., Rwibasira, P., Zhang, Y., et al. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113762 · Cited by 43
Precise base editing for the in vivo study of developmental signaling and human pathologies in zebrafish
Rosello, M., Vougny, J., Czarny, F., Mione, M., Concordet, J., Albadri, S., & Bene, F. D. (2021) · eLife · doi:10.7554/elife.65552 · Cited by 44
Highly efficient activation of endogenous gene in grape using CRISPR/dCas9-based transcriptional activators
Ren, C., Li, H., Liu, Y., Li, S., & Liang, Z. (2022) · Horticulture Research · doi:10.1093/hr/uhab037 · Cited by 42
Chromatin remodeler CHD7 regulates the stem cell identity of human neural progenitorsPreprint
MuhChyi, C., Sanosaka, T., Okuno, H., Zhou, Z., Koya, I., Banno, S., Andoh-Noda, T., Tabata, Y., Shimamura, R., Hayashi, T., et al. (2018) · Genes & Development · doi:10.1101/gad.301887.117 · Cited by 43
Genome-editing strategies for treating human retinal degenerations
Quinn, J., Musa, A., Kantor, A., McClements, M. E., Cehajic-Kapetanovic, J., MacLaren, R. E., & Xue, K. (2021) · Human Gene Therapy · doi:10.1089/hum.2020.231 · Cited by 41
Metabolic engineering for the synthesis of steviol glycosides: current status and future prospects
Zhou, X., Gong, M., Lv, X., Liu, Y., Li, J., Du, G., & Liu, L. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11419-3 · Cited by 41
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins
C., M. A. Z., Moore, H. J., Smith, T. J. S., Powell, J. E., Ahsan, N. S., Zhang, S., & Gaj, T. (2023) · Nature Communications · doi:10.1038/s41467-023-42147-z · Cited by 36
Rapid Knockout and Reporter Mouse Line Generation and Breeding Colony Establishment Using EUCOMM Conditional-Ready Embryonic Stem Cells: A Case Study
Coleman, J. L. J., Brennan, K., Ngo, T., Balaji, P., Graham, R. M., & Smith, N. J. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00105 · Cited by 42
Keeping CRISPR/Cas on-Target
Jamal, M., Khan, F. A., Lin, D., Habib, Z., Dai, J., & Cao, G. (2016) · Current Issues in Molecular Biology · doi:10.21775/cimb.020.001 · Cited by 41
Interaction of plant defense compounds with the insect gut: new insights from genomic and molecular analyses
Howe, G. A., & Herde, M. (2015) · Current Opinion in Insect Science · doi:10.1016/j.cois.2015.03.004 · Cited by 41
CrisprGE: a central hub of CRISPR/Cas-based genome editing
Kaur, K., Tandon, H., Gupta, A., & Kumar, M. (2015) · Database · doi:10.1093/database/bav055 · Cited by 41
Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis
Lee, R. T. H., Ng, A. S. M., & Ingham, P. W. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166020 · Cited by 41
Rapid and efficient CRISPR/Cas9 gene inactivation in human neurons during human pluripotent stem cell differentiation and direct reprogramming
Rubio, A., Luoni, M., Giannelli, S. G., Radice, I., Iannielli, A., Cancellieri, C., Berardino, C. D., Regalia, G., Lazzari, G., Menegon, A., et al. (2016) · Scientific Reports · doi:10.1038/srep37540 · Cited by 41
GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
Zhu, L. J., Lawrence, M., Gupta, A., Pagès, H., Küçükural, A., Garber, M. G., & Wolfe, S. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-3746-y · Cited by 42
Human induced pluripotent stem cell-derived vascular smooth muscle cells: differentiation and therapeutic potential
Ayoubi, S., Sheikh, S. P., & Eskildsen, T. V. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx125 · Cited by 39
A Comparison of Techniques to Evaluate the Effectiveness of Genome Editing
Germini, D., Tsfasman, T., Zakharova, V., Sjakste, N., Lipinski, M., & Vassetzky, Y. S. (2017) · Trends in biotechnology · doi:10.1016/j.tibtech.2017.10.008 · Cited by 41
Whole-genome sequencing reveals highly specific gene targeting by in vitro assembled Cas9-ribonucleoprotein complexes in Aspergillus fumigatus
Abdallah, Q. A., Souza, A. C. O., Martín‐Vicente, A., Ge, W., & Fortwendel, J. R. (2018) · Fungal Biology and Biotechnology · doi:10.1186/s40694-018-0057-2 · Cited by 40
Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis
O’Brien, S. A., Lee, K., Fu, H., Lee, Z., Le, T. S., Stach, C. S., McCann, M. G., Zhang, A. Q., Smanski, M. J., Somia, N. V., et al. (2018) · Biotechnology Journal · doi:10.1002/biot.201800226 · Cited by 41
Allograft Inflammatory Factor 1 as an Immunohistochemical Marker for Macrophages in Multiple Tissues and Laboratory Animal Species
Donovan, K. M., Leidinger, M., McQuillen, L. P., Goeken, J. A., Hogan, C. M., Harwani, S. C., Flaherty, H. A., & Meyerholz, D. K. (2018) · Comparative Medicine · doi:10.30802/aalas-cm-18-000017 · Cited by 41

Authors: Sander, J. D., & Joung, J. K.
Affiliations: Harvard University (US)
Corresponding author: Joung, J Keith
ORCID: Sander, Jeffry D
Joung, J Keith
Venue: Nature Biotechnology
Publisher: Springer Science and Business Media LLC
Published: 2014-03-02
Volume: 32
Issue: 4
Pages: 347-355
ISSN: 0733-222X (ISSN-L)
1087-0156
1546-1696
DOI: 10.1038/nbt.2842
PMC: PMC4022601
OpenAlex: W2039705224
Cited by: 3,153
References: 102
Citations by year: 2026: 79 · 2025: 153 · 2024: 167 · 2023: 166 · 2022: 233 · 2021: 225 · 2020: 271 · 2019: 298 · 2018: 379 · 2017: 368 · 2016: 384 · 2015: 300 · 2014: 124
FWCI: 36.95
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature Biotechnology (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute of General Medical Sciences (DP1GM105378, R01GM088040)
National Center for Chronic Disease Prevention and Health Promotion (DP1 GM105378)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: CRISPR/Cas9, genome editing, RNA-guided nucleases, engineered nucleases, gene expression regulation, targeted mutagenesis, molecular therapeutics
MeSH terms: Animals, Genetic Engineering, Humans, Rabbits, Genomics, Mice, Rats, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

CRISPR-Cas systems for editing, regulating and targeting genomes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks